Literature DB >> 20421860

Metastatic pancreatic endocrine tumor presenting as thoracic spinal cord compression.

Todd Alin Eads1, Eyas M Hattab, Richard B Rodgers.   

Abstract

STUDY
DESIGN: A case report.
OBJECTIVE: The authors present a rare case of metastatic nonfunctioning neuroendocrine tumor of the pancreas presenting as thoracic spinal cord compression. SUMMARY OF BACKGROUND DATA: Pancreatic endocrine tumors (PETs) are a slow-growing subset of pancreatic tumors. They can be classified as either functioning or nonfunctioning. To our knowledge, this is the second reported case of a PET presenting as spinal cord compression.
METHODS: The clinical course, radiologic features, pathology, and outcome of the metastasis of PET are reported.
RESULTS: A 59-year-old woman presenting with a 2-week history of midthoracic back pain and early signs of myelopathy. A computed tomography scan and magnetic resonance imaging revealed multiple mildly enhancing lesions within T5, T7, T8, and L1 vertebral bodies with ventral epidural and bilateral T8-T9 neuroforaminal soft tissue extension causing severe spinal canal stenosis. A computed tomography-guided biopsy was inconclusive, and we performed a T7-T9 laminectomy with T8 bilateral transpedicular decompression and T6 to T10 pedicle screw fixation and posterolateral fusion with subtotal resection of the tumor. Pathology was consistent with low-grade neuroendocrine tumor. The patient recovered well, and an octreotide scan ultimately revealed an area of abnormal uptake within the body of the pancreas.
CONCLUSION: We have reported a rare case of a metastatic PET presenting as spinal cord compression.

Entities:  

Mesh:

Year:  2010        PMID: 20421860     DOI: 10.1097/BRS.0b013e3181cb4730

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  1 in total

1.  Intramedullary spinal cord metastasis from pancreatic neuroendocrine tumor.

Authors:  Jung Ho Kim; Chang Lim Hyun; Sang Hoon Han
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.